Junbiao Wu

Junbiao Wu

Auto-generated profile, based on publicly available information

Junbiao Wu

Shenzhen Hospital (Futian) of Guangzhou University of Chinese Medicine, Shenzhen, Guangdong, PR China; The Second Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, PR China

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2021 in European Journal of Pharmacology
Verified
Journal Article
Closed access
DCDandan Chen
Dandan Chen
YLYaoyu Liu
Yaoyu Liu
JCJunqi Chen
Junqi Chen
HLHua Lin
Hua Lin
HGHuijuan Guo
Huijuan Guo
JWJunbiao Wu
Junbiao Wu

29 July 2023 in Life Sciences
Verified
Journal Article
Closed access
YLYaoyu Liu
Yaoyu Liu
XLXiaojie Li
Xiaojie Li
MZMinglan Zhao
Minglan Zhao
YWYifan Wu
Yifan Wu
YXYuan Xu
Yuan Xu
JWJunbiao Wu
Junbiao Wu

1 May 2019 in International Immunopharmacology
Verified
Journal Article
Closed access
LBLixia Bai
Lixia Bai
HLHonglian Li
Honglian Li
JLJicheng Li
Jicheng Li
JSJianping Song
Jianping Song
YZYuan Zhou
Yuan Zhou
JZJiu-Yao Zhou
Jiu-Yao Zhou

2 May 2022 in Bioengineered
Verified
Journal Article
Open access
JCJunqi Chen
Junqi Chen
QHQinghong Hu
Qinghong Hu
YLYini Luo
Yini Luo
LLLina Luo
Lina Luo
HLHua Lin
Hua Lin
JWJunbiao Wu
Junbiao Wu
The abnormal proliferation and inflammatory response of the mesangial cells play a crucial role in the progression of membranous nephropathy (MN). Herein, this study aimed to investigate the therapeutic effect of Salvianolic acid B (SalB) on MN-induced mesangial abnormalities and its underlying mechanisms. MN models were established in cationic bovine serum albumin-induced Sprague-Dawley rats and lipopolysaccharide-induced human mesangial cells (HMCs). Following SalB and microRNA-145-5p antagomir treatment, kidney function was investigated by 24-hours urine protein, serum creatinine, and blood urea nitrogen. Pathological changes of kidney were investigated by Periodic acid Schiff staining. CD68 and IgG were detected by immunofluorescence in glomerulus. Mesangial autophagosomes were observed by transmission electron microscope. MicroRNA-145-5p inhibitor, mimic, LY294002, and SalB were used to treat with HMCs. In kidney and HMCs, IL-1 β, IL-2, IL-6, TNF- α and microRNA-145-5p was detected by quantitative real-time PCR. Phosphatidylinositol 3-kinase (PI3K), phosphorylated AKT, AKT, beclin1, and microtubule-associated protein light chain 3 (LC3) levels were detected by Western blot. HMCs proliferation and cycle were detected by Cell Counting Kit-8 and flow cytometry. LC3 were detected by LC3-dual-fluorescent adenovirus in HMCs. Our results showed that SalB significantly ameliorated kidney function and pathological changes. Furthermore, it significantly alleviated proliferation, inflammation and activated autophagy in mesangial cells. Moreover, microRNA-145-5p antagomir accentuated MN while microRNA-145-5p inhibitor and LY294002 encouraged proliferation and inflammation through PI3K/AKT pathway in HMCs. Collectively, our study demonstrated that SalB activated renal autophagy to reduce cell proliferation and inflammation of MN, which was mediated by microRNA-145-5p to inhibit PI3K/AKT pathway, and ultimately attenuated MN. GRAPHICAL ABSTRACT

14 October 2017 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
JWJunbiao Wu
Junbiao Wu
YHYu He
Yu He
YLYining Luo
Yining Luo
LZLei Zhang
Lei Zhang
HLHua Lin
Hua Lin
JZJiu-Yao Zhou
Jiu-Yao Zhou

5 July 2025 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
QHQinghong Hu
Qinghong Hu
MZMinglan Zhao
Minglan Zhao
HWHuanhuan Wang
Huanhuan Wang
XLXiaojie Li
Xiaojie Li
FWFangting Wang
Fangting Wang
JWJunbiao Wu
Junbiao Wu